ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Beware Antitrust Regulations When Considering Healthcare Mergers

by Steven M. Harris, Esq. • April 5, 2015

  • Tweet
  • Email
Print-Friendly Version

Beware Antitrust Regulations When Considering Healthcare MergersThe Antitrust Division of the Federal Trade Commission (FTC), the Department of Justice (DOJ), and state attorneys general have been aggressively enforcing antitrust laws in the healthcare market. The FTC views the challenges to certain healthcare transactions as an important element in controlling the cost of healthcare where the transactions have, in its view, an anticompetitive affect on the market. Navigating the antitrust laws is important for healthcare systems, hospitals and physician practices that are looking at consolidation, mergers or other forms of collaboration as a means to meet the current economic constraints and other challenges in the healthcare industry.

You Might Also Like

  • CVS–Aetna Merger May Reshape Healthcare Delivery in the U.S.
  • Navigating a Healthcare Transaction
  • Healthcare Providers Must Comply with HIPAA Privacy Practices
  • How to Avoid a Healthcare Data Breach
Explore This Issue
April 2015

The discussions and activities associated with entering into a merger or other collaboration between and among providers must comply with the antitrust laws, which prohibit any concerted action that suppresses, or that facilitates the suppression of, competition. A number of federal antitrust laws exist and are generally enforced by the FTC and the DOJ. State antitrust laws are enforced by the state attorney general.

Transaction Discussion & Negotiation

The meetings, discussions and communications among providers in furtherance of a potential merger may constitute concerted action for antitrust purposes when they involve independently practicing physicians and physician groups or healthcare entities that may be viewed as competitors. Accordingly, any discussions or actions that could lead to anticompetitive conduct need to be avoided.

Areas that will create significant risk during the analysis and negotiation of a potential merger include:

  1. Any discussion or dissemination of the current fees charged by providers, desired reimbursement levels or possible changes in those fees or levels;
  2. Any agreement on a specific method of charging for services;
  3. Any discussion of limiting the geographic area served, the entities to be solicited, the services provided by a provider, or any discussion regarding market allocation;
  4. Any suggestion of boycott of, or retaliatory action against, a managed care organization, insurer, or other entity; and
  5. Sharing of payer contracts that the providers have in common.

At the beginning of any merger analysis and negotiation, transaction and antitrust counsel should provide or facilitate an evaluation of the potential antitrust implications and may prepare and circulate a checklist that clearly identifies permissible and impermissible discussion topics.

Steven M. Harris, EsqFalling within a safety zone allows a greater degree of comfort that the transaction will not be deemed to violate antitrust laws.

Level of Integration

As providers face increasing challenges seeking reimbursement for services, many are looking for ways to collaborate to facilitate improved payer arrangements. Agreements on prices or price levels for patients are per se illegal under antitrust laws, but joint price negotiations by competing healthcare providers may be permissible if properly evaluated to determine (a) if there is sufficient financial and clinical integration and (b) if the agreement is reasonably necessary to accomplish the procompetitive benefits of the integration.

Pages: 1 2 3 | Single Page

Filed Under: Departments, Legal Matters Tagged With: antitrust, legal, mergersIssue: April 2015

You Might Also Like:

  • CVS–Aetna Merger May Reshape Healthcare Delivery in the U.S.
  • Navigating a Healthcare Transaction
  • Healthcare Providers Must Comply with HIPAA Privacy Practices
  • How to Avoid a Healthcare Data Breach

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.